Applied Therapeutics Aktie
WKN DE: A2PHHB / ISIN: US03828A1016
19.03.2025 12:45:18
|
Applied Therapeutics Names Todd Baumgartner As Chief Regulatory Officer
(RTTNews) - Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company, on Wednesday announced the appointment of Todd Baumgartner as Chief Regulatory Officer.
Baumgartner, with over 35 years of experience, will be responsible for heading Applied's global regulatory strategy.
Before joining the company, Baumgartner served as Senior Vice President of Global Regulatory Affairs, Pharmacovigilance, and Biometrics at Ovid Therapeutics.
Tuesday, Applied Therapeutics had closed 4.70% lesser at $0.52 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Applied Therapeutics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Applied Therapeutics Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Applied Therapeutics Inc Registered Shs | 0,34 | 0,00% |
|